Codexis (CDXS) News Today $2.21 -0.09 (-3.91%) As of 02:57 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period CenterBook Partners LP Makes New $4.69 Million Investment in Codexis, Inc. (NASDAQ:CDXS)CenterBook Partners LP purchased a new position in shares of Codexis, Inc. (NASDAQ:CDXS - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 982,848 shares of the biotechnology company's stock, valued at apApril 11, 2025 | marketbeat.comMajor Investment Alert: Opaleye Management Inc. Boosts Stake in Codexis!April 9, 2025 | tipranks.comCodexis Announces Board Member Retirement in April 2025April 9, 2025 | tipranks.comCodexis Announces Byron Dorgan to Retire from Board of DirectorsApril 9, 2025 | globenewswire.comCodexis Announces Byron Dorgan to Retire from Board of DirectorsApril 9, 2025 | globenewswire.comCodexis shares bought by Opaleye Management for $198,380April 9, 2025 | investing.comCodexis sees significant stock purchase by Opaleye Management, Inc. for $271,788April 3, 2025 | investing.comCodexis appoints new independent board memberApril 2, 2025 | uk.investing.comCodexis appoints new independent board memberApril 2, 2025 | uk.investing.comCodexis stock hits 52-week low at $2.43 amid market challengesApril 2, 2025 | investing.comCodexis Appoints Cynthia Collins to Board of DirectorsMarch 31, 2025 | tipranks.comCodexis, Inc. (NASDAQ:CDXS) Short Interest Up 50.8% in MarchCodexis, Inc. (NASDAQ:CDXS - Get Free Report) was the target of a large increase in short interest in March. As of March 15th, there was short interest totalling 4,570,000 shares, an increase of 50.8% from the February 28th total of 3,030,000 shares. Based on an average daily trading volume, of 843,500 shares, the short-interest ratio is currently 5.4 days. Currently, 5.7% of the shares of the stock are sold short.March 31, 2025 | marketbeat.comInvestors should buy Codexis following contract news, says Craig-HallumMarch 26, 2025 | markets.businessinsider.comOpaleye Management Inc. Expands Stake in Codexis Inc.March 25, 2025 | gurufocus.comCodexis announces first revenue-generating contract for ECO Synthesis servicesMarch 24, 2025 | markets.businessinsider.comCodexis Shares Rise After Contract for Its Innovation LabMarch 24, 2025 | marketwatch.comCodexis Announces First Revenue-Generating Contract for ECO Synthesis™ Manufacturing ServicesMarch 24, 2025 | finance.yahoo.comFY2025 EPS Estimates for Codexis Cut by Cantor FitzgeraldCodexis, Inc. (NASDAQ:CDXS - Free Report) - Equities researchers at Cantor Fitzgerald decreased their FY2025 earnings per share estimates for Codexis in a report released on Monday, March 10th. Cantor Fitzgerald analyst K. Kluska now anticipates that the biotechnology company will earn ($0.60) peMarch 13, 2025 | marketbeat.comCodexis, Inc. (NASDAQ:CDXS) Stock Holdings Lifted by Telemark Asset Management LLCTelemark Asset Management LLC lifted its holdings in Codexis, Inc. (NASDAQ:CDXS - Free Report) by 11.3% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 3,000,000 shares of the biotechnology company's stock after buying an additional 303,589March 13, 2025 | marketbeat.comCantor Fitzgerald Sticks to Their Buy Rating for Codexis (CDXS)March 10, 2025 | markets.businessinsider.comCodexis Announces New Employment Inducement GrantsMarch 7, 2025 | gurufocus.comCodexis Announces New Employment Inducement GrantsMarch 7, 2025 | globenewswire.comCantor Fitzgerald Lifts Earnings Estimates for CodexisCodexis, Inc. (NASDAQ:CDXS - Free Report) - Analysts at Cantor Fitzgerald upped their FY2025 earnings per share (EPS) estimates for Codexis in a research report issued on Tuesday, March 4th. Cantor Fitzgerald analyst K. Kluska now anticipates that the biotechnology company will post earnings perMarch 7, 2025 | marketbeat.comEarnings call transcript: Codexis Q4 2024 misses earnings, stock slipsMarch 1, 2025 | investing.comCodexis (NASDAQ:CDXS) Releases Earnings Results, Misses Expectations By $0.09 EPSCodexis (NASDAQ:CDXS - Get Free Report) posted its earnings results on Thursday. The biotechnology company reported ($0.13) earnings per share for the quarter, missing analysts' consensus estimates of ($0.04) by ($0.09). Codexis had a negative net margin of 96.35% and a negative return on equity of 71.56%.February 28, 2025 | marketbeat.comStifel Nicolaus Sticks to Their Buy Rating for Codexis (CDXS)February 28, 2025 | markets.businessinsider.comCodexis Inc (CDXS) Q4 2024 Earnings Call Highlights: Strategic Partnerships and Revenue Growth ...February 28, 2025 | finance.yahoo.comQ4 2024 Codexis Inc Earnings Call TranscriptFebruary 28, 2025 | gurufocus.comCodexis, Inc. (CDXS) Q4 2024 Earnings Call TranscriptFebruary 27, 2025 | seekingalpha.comCodexis shares tumble as Q4 results miss estimates, outlook disappointsFebruary 27, 2025 | au.investing.comCodexis sees FY25 revenue $64M-$68M, consensus $66.61MFebruary 27, 2025 | markets.businessinsider.comCodexis Inc (CDXS) Reports Q4 Revenue of $59.3 Million, Misses Estimate; Annual EPS of -0. ...February 27, 2025 | gurufocus.comCraig-Hallum Sticks to Its Buy Rating for Codexis (CDXS)February 27, 2025 | markets.businessinsider.comCodexis (NASDAQ:CDXS) Stock Passes Above 200 Day Moving Average - Here's WhyCodexis (NASDAQ:CDXS) Stock Price Crosses Above 200-Day Moving Average - Here's What HappenedFebruary 27, 2025 | marketbeat.comCodexis (CDXS) to Release Quarterly Earnings on WednesdayCodexis (NASDAQ:CDXS) will be releasing earnings after the market closes on Wednesday, February 26. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=666462)February 19, 2025 | marketbeat.comCodexis to Participate in TD Cowen 45th Annual Health Care ConferenceFebruary 19, 2025 | markets.businessinsider.comBaillie Gifford & Co. Sells 119,775 Shares of Codexis, Inc. (NASDAQ:CDXS)Baillie Gifford & Co. trimmed its holdings in shares of Codexis, Inc. (NASDAQ:CDXS - Free Report) by 6.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,694,025 shares of the biotechnologyFebruary 18, 2025 | marketbeat.comCodexis Announces New Employment Inducement GrantsFebruary 14, 2025 | globenewswire.comCodexis to Report Fourth Quarter and Fiscal Year 2024 Financial Results on February 27thFebruary 13, 2025 | globenewswire.comOpaleye Management Inc. Reduces Stake in Codexis Inc.February 13, 2025 | gurufocus.comCodexis sees $205,481 stock purchase by Opaleye managementFebruary 12, 2025 | msn.comabrdn plc Has $2.43 Million Stock Holdings in Codexis, Inc. (NASDAQ:CDXS)abrdn plc trimmed its stake in shares of Codexis, Inc. (NASDAQ:CDXS - Free Report) by 36.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 508,623 shares of the biotechnology company's stock after selling 291,787February 11, 2025 | marketbeat.comCodexis strengthens board with biotech veteran Arthur LevinFebruary 6, 2025 | msn.comCodexis, Inc. Appoints Dr. Arthur Levin to Strategic Advisory Board to Enhance Oligonucleotide ExpertiseFebruary 6, 2025 | quiverquant.comCodexis (NASDAQ:CDXS) investors are sitting on a loss of 79% if they invested three years agoFebruary 6, 2025 | finance.yahoo.comCodexis Appoints Arthur Levin, PhD, to Strategic Advisory BoardFebruary 6, 2025 | globenewswire.comShort Interest in Codexis, Inc. (NASDAQ:CDXS) Increases By 20.5%Codexis, Inc. (NASDAQ:CDXS - Get Free Report) was the recipient of a large growth in short interest in January. As of January 15th, there was short interest totalling 2,290,000 shares, a growth of 20.5% from the December 31st total of 1,900,000 shares. Based on an average trading volume of 668,900 shares, the short-interest ratio is presently 3.4 days.February 2, 2025 | marketbeat.comInspire Investing LLC Invests $405,000 in Codexis, Inc. (NASDAQ:CDXS)Inspire Investing LLC acquired a new stake in Codexis, Inc. (NASDAQ:CDXS - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 84,988 shares of the biotechnology company's stock, valued at apJanuary 26, 2025 | marketbeat.comCodexis, Inc. (NASDAQ:CDXS) Shares Sold by Assenagon Asset Management S.A.Assenagon Asset Management S.A. lowered its stake in shares of Codexis, Inc. (NASDAQ:CDXS - Free Report) by 73.9% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 287,864 shares of the biotechnology company's stock after selling 815,578 shares durJanuary 24, 2025 | marketbeat.comCantor Fitzgerald Forecasts Codexis FY2025 EarningsCodexis, Inc. (NASDAQ:CDXS - Free Report) - Stock analysts at Cantor Fitzgerald issued their FY2025 earnings estimates for shares of Codexis in a research note issued to investors on Tuesday, January 21st. Cantor Fitzgerald analyst K. Kluska expects that the biotechnology company will earn ($0.51January 23, 2025 | marketbeat.com Remove Ads Get Codexis News Delivered to You Automatically Sign up to receive the latest news and ratings for CDXS and its competitors with MarketBeat's FREE daily newsletter. Email Address CDXS Media Mentions By Week CDXS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CDXS News Sentiment▼0.800.80▲Average Medical News Sentiment CDXS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CDXS Articles This Week▼73▲CDXS Articles Average Week Remove Ads Get Codexis News Delivered to You Automatically Sign up to receive the latest news and ratings for CDXS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MYGN News ZBIO News RIGL News VNDA News EBS News VSTM News XOMA News SGMO News LXRX News RGLS News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CDXS) was last updated on 4/15/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon’s Silver Play? Trump Clears the PathNothing is confirmed—yet. But Musk has disrupted every industry he's touched, and Trump's policies make the ti...Priority Gold | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Codexis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Codexis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
